J. Wedzicha (London, United Kingdom), H. Ghedira (Ariana, Tunisia)
A study of exacerbations by Gram-negative organisms in chronic obstructive pulmonary disease (COPD)
P. Sobradillo, F. Baranda, M. Iriberri, J. Amilibia, J. Barron, C. Vazquez (Bilbao, Barakaldo (Bizkaia), Spain)
|  |
Thromboprophylaxis and the relationship between C-reactive protein and plasma fibrinogen in patients with acute exacerbations of COPD
M. Jones, E. Evans (Swansea, United Kingdom)
| |
Time course of systemic inflammatory markers during acute exacerbation of COPD
G. Nuralieva, S. Avdeev, A. Chuchalin (Moscow, Russian Federation)
| |
Viral etiology of acute exacerbations of chronic obstructive pulmonary disease in Hong Kong
F. Ko, M. Ip, P. Chan, M. Chan, K. To, S. Ng, D. Hui (Hong Kong)
| |
Arterial lactate levels in cases of COPD with respiratory failure
M. Buyuksirin, G. Polat, A. Usalan, Z. Asuk, G. Tibet (Izmir, Turkey)
|  |
Serum magnesium levels in acute exacerbation of COPD
E. C. Seyhan, S. Altin, E. Cetinkaya, S. N. Sokucu, S. Acar, P. Ozkan (Istanbul, Turkey)
| |
Vitamin C level in the serum of smokers and non-smokers with COPD in stable state and during exacerbation
L. Corkovic, T. Milosevic, S. Jelic, V. Miloskovic, D. Begovic, M. Obradovic (Belgrade, Kragujevac, Mladenovac, Serbia And Montenegro)
| |
Efficiency of therapy of COPD exacerbations and 1-year survival rate after hospitalization
M. Savelyeva, N. Berdnikova, A. Tsoy (Moscow, Russian Federation)
| |
Prevention of COPD exacerbations and reduction of health care utilization with erdosteine
M. Moretti, M. Nicola (Modema, Milano, Italy)
| |
Inhaler technique and peak inspiratory flow rates in patients with acute exacerbated COPD
L. Cekici, B. Weinhofer, O. C. Burghuber, A. Valipour (Vienna, Austria)
| |
Determinants of depression at exacerbation in chronic obstructive pulmonary disease
J. Quint, R. Baghai-Ravary, G. Donaldson, J. Wedzicha (London, United Kingdom)
| |
Risk factors contributing to mortality in patients with COPD developing acute respiratory failure
P. J. Chang, W. T. Liu, C. D. Huang, K. Y. Lee, C. H. Wang, H. P. Kuo (Taoyuan, Taiwan, Province Of China)
| |
Performance of rapid, bedside whole blood C-reactive protein (CRP) test as a diagnostic test for bacterial infection and pneumonia in patients with acute exacerbation of chronic obstructive pulmonary disease (AE COPD)
G. Baimakanova, P. Zubairova, S. Avdeev, A. Chuchalin (Moscow, Russian Federation)
| |
The effect of exacerbation and physiological factors on health related quality of life in patients with stable chronic obstructive pulmonary disease
K. Ansari, M. Shamssain, N. Keaney, G. Burns, M. Farrow (Sunderland, England, Newcastle upon Tyne, England, United Kingdom)
| |
Gastroesophageal pathologic changes in patients with COPD
K. Mise, I. Jukic, Z. Sundov, D. Arar, A. Bradaric (Split, Croatia)
| |
The main reasons of exacerbation and hospitalization of COPD patients
D. Barkhatova, T. Pestrikova, I. Martynenko, V. Nevzorova (Vladivostok, Russian Federation)
| |
The incidence of laryngopharyngeal reflux in patients with COPD and the effect of laryngopharyngeal reflux on the rate of exacerbations of COPD and COPD symptom scores
E. Eryuksel, M. Dogan, S. Olgun, M. A. Sehitoglu, T. Çelikel (Istanbul, Turkey)
| |
The role of soluble intercellular adhesion molecule-1 (sICAM-1) in progress of COPD
L. Konopkina, T. Pertseva (Dnipropetrovs‘k, Ukraine)
| |
BODE index as predictor of exacerbation occurrence in ambulatory patients with COPD
M. Faganello, S. Minamoto, F. Sanchez, N. Pelegrino, P. Lucheta, I. Godoy (Botucatu, São Paulo, Lins, Sao Paulo, Araçatuba, São Paulo, Brazil)
| |